Identification and validation of different interactions between ceRNAs in models that do not fully reflect pathomechanisms of DMs may lead to misinterpretation of findings or incorrect results, especially in the context of low DMPK and CNBP/ZNF9 transcript levels in affected DM patients’ cells. The gene discussed is CNBP; the disease is nephrotic syndrome, type 4.